Skip to main content

Use and Misuse of Albuterol Metered Dose Inhalers

Buy Article:

$39.50 plus tax (Refund Policy)

Inhaled metered dose beta2 aerosols in the patient willing and able to cooperate are a decided advance in therapy, combining a minimum of side effects with a maximum of action. Continuing development of delivery systems may broaden their use to the infirm and uncoordinated patient. Tachyphylaxis is not a serious problem in their ordinary use, but their exact potential to produce tachyphylaxis under conditions of increased use needs more study. Use of inhaled beta2 aerosols in the patient with "fixed" obstruction of the airways is still of considerable value, and may be reflected more in the total vital capacity than the FEV1 determination. Combination of the aerosols with a systemic bronchodilator, either theophylline or a beta2 agonist or their combination, augments the bronchodilation, and in particular, is useful for the patient with severe asthma. However, the severely asthmatic patient, or the patient developing a severe attack, must be adequately coached and managed in the use of corticosteroids since the inflammatory consequences of asthma do not respond significantly to bronchodilators, and the patient may be unaware of the risk of his attack.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics

Document Type: Research Article

Affiliations: Pulmonary Section, Hines Veteran Administration Hospital, Hines, Illinois; Loyola Stritch School of Medicine, Maywood, Illinois

Publication date: 1983-12-01

More about this publication?
  • Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.

    The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.

    Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.

    Articles marked "F" offer free full text for personal noncommercial use only.

    The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Information for Advertisers
  • Reprint Requests
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more